Chemotherapy Induced Peripheral Neuropathy Treatment Market will reach 1880 million US$ in 2023

New report published by Global Info Research which offers insights on the global Chemotherapy Induced Peripheral Neuropathy Treatment market.

CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.

Click to view the full report TOC, figure and tables：
https://www.globalinforesearch.com/global-chemotherapy-induced-peripheral-neuropathy-treatment-market_p95513.html

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market: Forecast by Type / Application / Region

The classification of Chemotherapy Induced Peripheral Neuropathy Treatment includes Calcium channel α2-delta ligands, Antidepressants, Opioids and Other Drugs. And the proportion of Opioids in 2017 is about 27%, and the proportion is in decreasing trend from 2013 to 2017.

Chemotherapy Induced Peripheral Neuropathy Treatment is widely used for CIPN cause by Platinum Agents, Taxanes, Vinca Alkaloids and Others. The most proportion of Chemotherapy Induced Peripheral Neuropathy Treatment is used in Platinum Agents, and the proportion in 2017 is 42%.

North America is the largest sales place, with a sales market share nearly 41% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 27%.

The worldwide market for Chemotherapy Induced Peripheral Neuropathy Treatment is expected to grow at a CAGR of roughly 6.4% over the next five years, will reach 1880 million US$ in 2023, from 1300 million US$ in 2017, according to a new GIR (Global Info Research) study.

Global Nonferrous Metal Recycling Market:Key Players
Aptinyx
Asahi Kasei Pharma
Regenacy Pharmaceuticals
MAKScientific
Metys Pharmaceuticals
Nemus Bioscience
PledPharma
Sova Pharmaceuticals
DermaXon
Immune Pharmaceuticals
Kineta
Krenitsky Pharmaceuticals
PeriphaGen
Apexian Pharma
WinSanTor
Solasia Pharma

Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-chemotherapy-induced-peripheral-neuropathy-treatment-market_p95513.html

Related Information:
United States Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023
Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023
North America Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023
Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023
China Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023
EMEA Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2018 Forecast to 2023

About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Contact US :
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com

This release was published on openPR.